EUVIMEDEUVIMED entdecken
Open Access

Computing the inducibility of broadly neutralizing antibodies under a context-dependent model of affinity maturation: applications to sequential vaccine design

Joseph Mathews iD, Elizabeth Van Itallie, Yongkang Li, Kevin Wiehe iD, Scott C Schmidler iD

The Journal of Immunology · 2026

DOI: 10.1093/jimmun/vkaf234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2026. Verfasst von Joseph Mathews und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistical Science, Duke University, Durham, NC, United States. Hauptthemen laut MEDLINE: B-Lymphocytes, AIDS Vaccines, HIV Antibodies, Antibodies, Neutralizing. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Science Foundation, Duke Consortia for HIV/AIDS Vaccine Development, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A key challenge in B-cell lineage–based vaccine design is understanding the “inducibility” of target neutralizing antibodies—the ability of these antibodies to be elicited by presentation of an immunogen. Induction relies on a combination of stochastic diversification and immunogen-based selection, and as a result is heavily dependent on the probabilistic accessibility of induction pathways. We explored inducibility using a detailed stochastic model of the somatic hypermutation process—which captures the critical “context-dependence” of sequence mutation rates—coupled to a stochastic population model for B-cell clonal maturation. The model is used to calculate inducibilities for a set of critical mutations required by the HIV broadly neutralizing antibody (bnAb) CH235.12. The results provide insight into barriers to the elicitation of HIV bnAbs and explain experimental results observed in mouse models. Our models enable detailed analysis of maturation pathway probabilities, allowing us to identify opportunities for the design of boosting immunogens aimed at elicitation of CH235.12 via a sequential vaccination regimen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B-LymphocytesAIDS VaccinesHIV AntibodiesAntibodies, NeutralizingHIV InfectionsBroadly Neutralizing AntibodiesHIV-1Models, ImmunologicalHumansAnimalsAntibody AffinityMice

Stichwörter der Autor:innen

broadly neutralizing antibodycomputational immunologysomatic hypermutation

Substanzen

AIDS VaccinesHIV AntibodiesAntibodies, NeutralizingBroadly Neutralizing Antibodies

Autor:innen und Institutionen

  • Department of Statistical Science, Duke University, Durham, NC, United States.
  • Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.
  • Department of Computer Science, Duke University, Durham, NC, United States.
  • Program in Computational Biology and Bioinformatics, Duke University, Durham, NC, United States.

ORCID-Profile: Joseph Mathews, Kevin Wiehe, Scott C Schmidler

Förderung

  • National Science Foundation
  • Duke Consortia for HIV/AIDS Vaccine Development
  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Mathews, J., Van Itallie, E., Li, Y., Wiehe, K., & Schmidler, S. C. (2026). Computing the inducibility of broadly neutralizing antibodies under a context-dependent model of affinity maturation: applications to sequential vaccine design. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf234

Vancouver

Mathews J, Van Itallie E, Li Y, Wiehe K, Schmidler SC. Computing the inducibility of broadly neutralizing antibodies under a context-dependent model of affinity maturation: applications to sequential vaccine design. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkaf234

BibTeX
@article{Mathews2026,
  author = {Mathews, Joseph and Van Itallie, Elizabeth and Li, Yongkang and Wiehe, Kevin and Schmidler, Scott C},
  title = {Computing the inducibility of broadly neutralizing antibodies under a context-dependent model of affinity maturation: applications to sequential vaccine design},
  journal = {The Journal of Immunology},
  year = {2026},
  doi = {10.1093/jimmun/vkaf234}
}
Kostenlos starten →